Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-16 5:00 pm Purchase | 2023-11-15 | 13G | Lyra Therapeutics, Inc. LYRA | Point72 Asset Management, L.P. | 60,000 5.400% | 60,000 (New Position) | Filing History |
| 2023-08-25 4:15 pm Purchase | 2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA | Samsara BioCapital, L.P. | 55,605 5.600% | 55,605 (New Position) | Filing History |
| 2023-06-12 5:23 pm Purchase | 2023-05-31 | 13G | Lyra Therapeutics, Inc. LYRA | Citadel Advisors LLC | 57,931 5.900% | 57,931 (New Position) | Filing History |
| 2023-06-09 4:20 pm Purchase | 2023-05-31 | 13D | Lyra Therapeutics, Inc. LYRA | NBVM GP LLC | 120,629 12.200% | 36,253 (+42.97%) | Filing History |
| 2023-06-02 4:16 pm Purchase | 2023-05-31 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 255,151 25.800% | 72,217 (+39.48%) | Filing History |
| 2023-02-14 4:48 pm Purchase | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Nantahala Capital Management, LLC | 44,417 7.000% | 44,417 (New Position) | Filing History |
| 2023-02-14 4:40 pm Purchase | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Venrock Healthcare Capital Partners II, L.P. | 68,665 9.999% | 4 (+0.01%) | Filing History |
| 2023-02-14 3:47 pm Sale | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | PURA VIDA INVESTMENTS LLC | 43,146 6.780% | -12,496 (-22.46%) | Filing History |
| 2023-02-13 4:23 pm Unchanged | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | INTERSOUTH PARTNERS VII L P | 14,764 2.300% | 0 (Unchanged) | Filing History |
| 2023-02-07 5:05 pm Unchanged | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Polaris Venture Partners V, L.P. | 28,475 4.500% | 0 (Unchanged) | Filing History |
| 2022-11-08 4:12 pm Purchase | 2022-05-20 | 13G | Lyra Therapeutics, Inc. LYRA | PURA VIDA INVESTMENTS LLC | 55,642 8.740% | 55,642 (New Position) | Filing History |
| 2022-04-22 4:20 pm Purchase | 2022-04-12 | 13D | Lyra Therapeutics, Inc. LYRA | NBVM GP LLC | 84,376 13.200% | 50,097 (+146.15%) | Filing History |
| 2022-04-22 4:05 pm Purchase | 2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA | Venrock Healthcare Capital Partners II, L.P. | 68,661 9.999% | 68,661 (New Position) | Filing History |
| 2022-04-14 5:10 pm Purchase | 2022-04-07 | 13D | Lyra Therapeutics, Inc. LYRA | Perceptive Advisors LLC | 182,935 24.800% | 118,483 (+183.83%) | Filing History |
| 2022-02-14 4:30 pm Sale | 2021-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Ikarian Capital, LLC | 7,891 3.000% | -8,417 (-51.61%) | Filing History |
| 2022-02-14 2:55 pm Sale | 2021-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | ArrowMark Colorado Holdings, LLC | 0 0.000% | -12,966 (Position Closed) | Filing History |
| 2021-05-17 4:32 pm Sale | 2021-05-17 | 13G | Lyra Therapeutics, Inc. LYRA | RA Capital Management, L.P. | 0 0.000% | -16,317 (Position Closed) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | RA Capital Management, L.P. | 16,317 6.300% | 16,317 (New Position) | Filing History |
| 2021-02-16 1:29 pm Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | ArrowMark Colorado Holdings, LLC | 12,966 5.000% | 12,966 (New Position) | Filing History |
| 2021-02-16 07:49 am Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Ikarian Capital, LLC | 16,307 6.300% | 600 (+3.82%) | Filing History |